Form S-1 | Jotup

Assure Holdings Corp. Announces Pricing of $6 Million Underwritten Public Offering

Retrieved on:

Friday, May 12, 2023

Broad Street, Marketing, Kitchen Party (girl group), Enterprise file synchronization and sharing, Sale, Public expenditure, Prospectus, Form S-1, Form, Security (finance)

DENVER, May 12, 2023 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (NASDAQ: IONM) (“Assure Holdings” or the “Company”), a provider of intraoperative neuromonitoring and remote neurology services, today announced the pricing of an underwritten public offering of 5,000,000 shares of its common stock (or pre-funded warrants in lieu thereof) at an offering price to the public of $1.20 per share (or $1.199 per pre-funded warrant).

Key Points:

DENVER, May 12, 2023 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (NASDAQ: IONM) (“Assure Holdings” or the “Company”), a provider of intraoperative neuromonitoring and remote neurology services, today announced the pricing of an underwritten public offering of 5,000,000 shares of its common stock (or pre-funded warrants in lieu thereof) at an offering price to the public of $1.20 per share (or $1.199 per pre-funded warrant).
The closing of the offering is expected to occur on or about May 16, 2023, subject to the satisfaction of customary closing conditions.
The gross proceeds to the Company from the offering are expected to be approximately $6 million, before deducting the underwriters’ fees and other offering expenses payable by Assure.
The offering is being made only by means of a prospectus which is a part of the effective registration statement.

Post Holdings Partnering Corporation To Redeem its Public Shares and Will Not Consummate a Partnering Transaction

Retrieved on:

Thursday, May 11, 2023

Transfer, Commission, Tax, Electric Bond and Share Company v. Securities and Exchange Commission, Wind, Form S-1, Form, Finance Secretary (India), Chevrolet Series F, NYSE, Charter, Security (finance)

As stated in the Company’s Charter and in the Company’s registration statement on Form S-1 (Registration No.

Key Points:

As stated in the Company’s Charter and in the Company’s registration statement on Form S-1 (Registration No.
The Company anticipates that the last day of trading in the Public Shares will be May 26, 2023.
On or about May 30, 2023, the Public Shares will be deemed cancelled and will represent only the right to receive the per-share redemption price for the Public Shares to be announced at a later date (the “Redemption Amount”).
Beneficial owners of Public Shares held in “street name,” however, will not need to take any action in order to receive the Redemption Amount.

Vivid Seats Strengthens Position with Excellent Start to 2023

Retrieved on:

Tuesday, May 9, 2023

Forecasting, Form, Tax, Total, Form S-3, Form 10-K, Form S-1, Annual report, EBITDA, GAAP, Adjustment, Vivid Seats, Eastern Time Zone, Bookkeeping, Marketplace

CHICAGO, May 09, 2023 (GLOBE NEWSWIRE) -- Vivid Seats Inc. (NASDAQ: SEAT) (“Vivid Seats”, “we” or the “Company”), a leading marketplace that utilizes its technology platform to connect millions of buyers with thousands of ticket sellers across hundreds of thousands of events each year, today provided financial results for the first quarter ended March 31, 2023.

Key Points:

During the three months ended March 31, 2023, our Marketplace segment experienced 20,480 event cancellations compared to 91,400 event cancellations during the three months ended March 31, 2022.
During the three months ended March 31, 2023, our Resale segment experienced 685 event cancellations compared to 2,559 event cancellations during the three months ended March 31, 2022.
Vivid Seats now anticipates Marketplace GOV, Revenues and Adjusted EBITDA for the year ending December 31, 2023 to be:
Additional detail around the 2023 outlook will be available on the first quarter 2023 earnings call.
Participants may access the live webcast and supplemental earnings presentation on the events page of the Vivid Seats Investor Relations website at https://investors.vividseats.com/events-and-presentations .

OpGen Announces Closing of $3.5 Million Public Offering

Retrieved on:

Thursday, May 4, 2023

Exercise, Acuitas Therapeutics, Infection, Park Avenue, Enterprise file synchronization and sharing, Research, Sale, Nadine Opgen-Rhein, 3rd Floor, Prospectus, Form S-1, Medicine, Vii, Form, Security (finance), FDA

H.C. Wainwright & Co. acted as the exclusive placement agent for the offering.

Key Points:

H.C. Wainwright & Co. acted as the exclusive placement agent for the offering.
The gross proceeds from the offering, before deducting the placement agent's fees and other offering expenses, were approximately $3.5 million.
The offering was made only by means of a prospectus which forms a part of the effective registration statement.
A preliminary prospectus relating to the offering has been filed with the SEC.

OpGen Announces Pricing of $3.5 Million Public Offering

Retrieved on:

Tuesday, May 2, 2023

Exercise, Acuitas Therapeutics, Infection, Park Avenue, Free File, Research, Sale, Nadine Opgen-Rhein, 3rd Floor, Prospectus, Form S-1, Medicine, Vii, Form, Security (finance), FDA

The closing of the offering is expected to occur on or about May 4, 2023, subject to the satisfaction of customary closing conditions.

Key Points:

The closing of the offering is expected to occur on or about May 4, 2023, subject to the satisfaction of customary closing conditions.
H.C. Wainwright & Co. is acting as the exclusive placement agent for the offering.
The gross proceeds from the offering, before deducting the placement agent's fees and other offering expenses, are expected to be approximately $3.5 million.
The offering is being made only by means of a prospectus which forms a part of the effective registration statement.

MAIA Biotechnology, Inc. Announces Pricing of Public Offering

Retrieved on:

Tuesday, April 25, 2023

Biotechnology, Health, Pharmaceutical, Clinical Trials, Oncology, MAIA, Telephone, ThinkEquity, Cancer, Enterprise file synchronization and sharing, Research, Sale, Prospectus, Form S-1, State Street, Form, Security (finance), NYSE

MAIA Biotechnology, Inc. (NYSE: MAIA) (“MAIA” or the “Company”), a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer, today announced the pricing of an underwritten public offering of 2,222,200 shares of its common stock at a public offering price of $2.25 per share, for gross proceeds of approximately $5 million, before deducting underwriting discounts and other offering expenses.

Key Points:

MAIA Biotechnology, Inc. (NYSE: MAIA) (“MAIA” or the “Company”), a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer, today announced the pricing of an underwritten public offering of 2,222,200 shares of its common stock at a public offering price of $2.25 per share, for gross proceeds of approximately $5 million, before deducting underwriting discounts and other offering expenses.
In addition, MAIA has granted the underwriters a 45-day option to purchase up to an additional 333,300 shares of common stock to cover over-allotments at the public offering price, less the underwriting discount.
The offering is expected to close on April 27, 2023, subject to satisfaction of customary closing conditions.
ThinkEquity is acting as sole book-runner for the offering.

Sidus Space, Inc. Announces Pricing of $10 Million Public Offering

Retrieved on:

Thursday, April 20, 2023

Each share of Class A common stock and accompanying warrant is being sold to the public at a combined price of $0.33.

Key Points:

Each share of Class A common stock and accompanying warrant is being sold to the public at a combined price of $0.33.
The gross proceeds to the Company from this offering are expected to be approximately $10 million before deducting underwriting discounts, commissions and other offering expenses, and excluding the exercise of the over-allotment option, if any.
Boustead Securities, LLC and EF Hutton, division of Benchmark Investments, LLC are acting as the representatives of the underwriters for the offering.
A final prospectus related to the proposed offering will be filed and made available on the SEC’s website at https://www.sec.gov/ .

Pono Capital Three, Inc. Announces the Separate Trading of Its Class A Ordinary Shares and Warrants

Retrieved on:

Wednesday, March 29, 2023

Transfer, Madison, Telephone, Enterprise file synchronization and sharing, EDGAR, Bangladesh Securities and Exchange Commission, Sale, Prospectus, Form S-1, Acquisition, ATTN:, Form, Security (finance), EF Hutton

Holders of units will need to have their broker contact Continental Stock Transfer & Trust Company, the Company’s transfer agent, in order to separate the units into Class A ordinary shares and warrants.

Key Points:

Holders of units will need to have their broker contact Continental Stock Transfer & Trust Company, the Company’s transfer agent, in order to separate the units into Class A ordinary shares and warrants.
Those units not separated will continue to trade on the Nasdaq Global Market (“Nasdaq”) under the ticker symbol “PTHRU,” and the Class A ordinary shares and warrants that are separated will trade on Nasdaq under the symbols “PTHR” and “PTHRW,” respectively.
The securities described above were offered by the Company pursuant to a registration statement on Form S-1 (File No.
333-268283) that was originally filed with the Securities and Exchange Commission (“SEC”) on November 10, 2022 and declared effective on February 9, 2023.

Oak Woods Acquisition Corporation Announces Closing of $57,500,000 Initial Public Offering and Full Exercise of Over-Allotment Option

Retrieved on:

Tuesday, March 28, 2023

Benchmark, Exercise, Madison, ATTN:, Telephone, PLLC, Enterprise file synchronization and sharing, Sale, Prospectus, Form S-1, The Company, Acquisition, Form, Security (finance), EF Hutton

ONTARIO, CANADA, March 28, 2023 (GLOBE NEWSWIRE) -- Oak Woods Acquisition Corporation (the "Company") announced today the closing of its initial public offering of 5,750,000 units at $10.00 per unit, including 750,000 units issued pursuant to the full exercise by the underwriters of their over-allotment option.

Key Points:

ONTARIO, CANADA, March 28, 2023 (GLOBE NEWSWIRE) -- Oak Woods Acquisition Corporation (the "Company") announced today the closing of its initial public offering of 5,750,000 units at $10.00 per unit, including 750,000 units issued pursuant to the full exercise by the underwriters of their over-allotment option.
The units are listed on Nasdaq ("Nasdaq") and began trading on March 24, 2023, under the ticker symbol "OAKUU".
Each redeemable warrant entitles the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share.
EF Hutton, division of Benchmark Investments, LLC (“EF Hutton”) acted as the sole book running manager for the offering.

TMT Acquisition Corp Announces Pricing of $60 Million Initial Public Offering

Retrieved on:

Tuesday, March 28, 2023

Park Avenue, Free File, Sale, Prospectus, Form S-1, Acquisition, Form, Security (finance)

Each right entitles the holder thereof to receive two-tenths (2/10) of one ordinary share upon consummation of the Company’s initial business combination.

Key Points:

Each right entitles the holder thereof to receive two-tenths (2/10) of one ordinary share upon consummation of the Company’s initial business combination.
The units are expected to trade on the Nasdaq Global Market (“Nasdaq”) under the ticker symbol “TMTCU” beginning on March 28, 2023.
The Company has granted the underwriter a 45-day option to purchase up to 900,000 additional units at the initial public offering price to cover over-allotments, if any.
333-259879) (the “Registration Statement”) relating to the securities to be sold in the initial public offering was declared effective by the U.S. Securities and Exchange Commission (the “SEC”) on March 27, 2023.